labetalol has been researched along with Hematoma in 5 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Hematoma: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Blood pressure (BP) reduction after intracerebral hemorrhage (ICH) is controversial, because of concerns that this may cause critical reductions in perihematoma perfusion and thereby precipitate tissue damage." | 2.79 | Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study. ( Buck, BH; Butcher, KS; Choi, V; Coutts, SB; Demchuk, AM; Dowlatshahi, D; Emery, DJ; Gould, BE; Hansen, MB; Hill, MD; Kate, MP; McCourt, R; Mouridsen, K; Østergaard, L, 2014) |
| "We present an unusual case of spinal cord ischemia from an acute type B intramural hematoma that was successfully treated with blood pressure elevation and drainage of cerebral spinal fluid." | 1.39 | Acute intramural hematoma of the aorta complicated by spinal cord ischemia. ( Cassiere, HA; Liang, D; Yu, PJ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, PJ | 1 |
| Cassiere, HA | 1 |
| Liang, D | 1 |
| Kate, MP | 1 |
| Hansen, MB | 1 |
| Mouridsen, K | 1 |
| Østergaard, L | 1 |
| Choi, V | 1 |
| Gould, BE | 1 |
| McCourt, R | 1 |
| Hill, MD | 1 |
| Demchuk, AM | 1 |
| Coutts, SB | 1 |
| Dowlatshahi, D | 1 |
| Emery, DJ | 1 |
| Buck, BH | 1 |
| Butcher, KS | 1 |
| Mondel, PK | 1 |
| Udare, AS | 1 |
| Anand, S | 1 |
| Kulkarni, AV | 1 |
| Kapadia, FN | 1 |
| Modhe, JM | 1 |
| Limaye, US | 1 |
| Koch, S | 1 |
| Romano, JG | 1 |
| Forteza, AM | 1 |
| Otero, CM | 1 |
| Rabinstein, AA | 1 |
| Tin, LN | 1 |
| Mulard, C | 1 |
| Talon, A | 1 |
| Garnier, JM | 1 |
| Lambert, A | 1 |
| Stroch-Marcy, A | 1 |
| Kamara, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Study of the Safety and Efficacy of Analgesia-first Minimal Sedation as an Early Antihypertensive Treatment for Spontaneous Intracerebral Hemorrhage[NCT03207100] | 338 participants (Actual) | Interventional | 2017-12-06 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for labetalol and Hematoma
| Article | Year |
|---|---|
Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cerebral Hemorrhage; Female; Hematoma; Humans; Hydral | 2014 |
Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety.
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Brain Edema; Feasibility Studies; Fema | 2008 |
3 other studies available for labetalol and Hematoma
| Article | Year |
|---|---|
Acute intramural hematoma of the aorta complicated by spinal cord ischemia.
Topics: Acute Disease; Administration, Oral; Adult; Antihypertensive Agents; Aortic Diseases; Blood Pressure | 2013 |
Cerebral hyperperfusion syndrome after endovascular reconstruction of carotid artery in high-flow carotid-jugular fistula.
Topics: Adult; Angiography, Digital Subtraction; Antihypertensive Agents; Arteriovenous Fistula; Carotid Art | 2014 |
[Subcapsular liver hematoma, a HELLP syndrome complication].
Topics: Adult; Cesarean Section; Combined Modality Therapy; Female; HELLP Syndrome; Hematoma; Humans; Labeta | 1994 |